The Relationship Between Osteoporosis and Sarcopenia Parameters in Postmenopausal Women Under 60

NCT07045012 | Not Yet Recruiting

• 1 other identifier: Beylikdüzüstateh20
• Study Type: observational
• Target: 52
• Locations: 0 countries
• Sites: N/A

Brief Summary

This cross-sectional study will include postmenopausal women under the age of 60 who visited the Physical Medicine and Rehabilitation outpatient clinic at Beylikdüzü State Hospital between June 25 and July 25, 2025. Participants must have undergone a bone mineral density (BMD) assessment within the past six months using Dual X-ray Absorptiometry (DXA). Both osteoporotic and non-osteoporotic patients will be enrolled. Sociodemographic data such as age, height, weight, and BMI will be recorded. Femoral neck and L1-L4 T-scores and BMD values will be obtained from existing DXA results. Information on osteoporosis treatment, presence of fecal incontinence, constipation, and medication use will be collected. In the second phase, sarcopenia will be assessed according to EWGSOP2 criteria using bioelectrical impedance analysis for skeletal muscle mass, handgrip strength, and the five-time sit-to-stand test. Differences between the osteoporotic and non-osteoporotic groups will be analyzed.

Conditions

Osteoporosis

Outcome Measures

Primary Outcomes (3)

• Skeletal Muscle Mass

  Measured by bioelectrical impedance analysis (BIA), this assesses the amount of muscle tissue in the body. Low skeletal muscle mass indicates sarcopenia.

  0 day

• Handgrip Strength

  This is a simple test to measure muscle strength. Reduced handgrip strength is a sign of sarcopenia.

  0 day

• 5 times chair stand test

  The Five Times Sit-to-Stand Test is a simple and widely used functional assessment tool to evaluate lower extremity muscle strength, balance, and mobility.

  0 day

Eligibility Criteria

• Age: 50 Years - 59 Years
• Sex: female
• Age Groups: Adult (18-64)
• Sampling Method: Probability Sample

Study Population

Postmenopausal women under 60 years

You may qualify if:

• Women under 60 years of age who are postmenopausal.
• Patients with or without a diagnosis of osteoporosis:
• Osteoporosis group: T-score ≤ -2.5 in femoral neck or L1-L4 region. Control group: T-score ≥ -1.0 in femoral neck and L1-L4 region.
• Patients who provide written informed consent to participate in the study.

You may not qualify if:

• Refusal to participate in the study.
• Presence of neuromuscular diseases that could cause muscle loss.
• History of infection, recent surgery, or trauma.
• Presence of psychiatric disorders.
• Cognitive impairment that could interfere with test performance or data reliability.
• Use of medications that could affect study outcomes (e.g., corticosteroids, muscle relaxants, or medications influencing bone/muscle metabolism).

Sponsors & Collaborators

• Beylikduzu State Hospital: lead

MeSH Terms

Conditions

Osteoporosis

Condition Hierarchy (Ancestors)

Bone Diseases, Metabolic; Bone Diseases; Musculoskeletal Diseases; Metabolic Diseases; Nutritional and Metabolic Diseases

Study Design

• Study Type: observational
• Observational Model: CASE CONTROL
• Time Perspective: CROSS SECTIONAL
• Target Duration: 1 Day
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Principle Investigator

Study Record Dates

• First Submitted: June 22, 2025
• First Posted: July 1, 2025
• Study Start: June 25, 2025
• Primary Completion: July 25, 2025
• Study Completion: July 25, 2025
• Last Updated: July 1, 2025

Record last verified: 2025-06